Article
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
The Journal of molecular diagnostics : JMD - 1 Sept 2018
Prieto-Potin Iván, Montagut Clara, Bellosillo Beatriz, Evans Matthew, Smith Matthew, Melchior Linea, Reiltin Werner, Bennett Michael, Pennati Veronica, Castiglione Francesca, Bürrig Karl-Friedrich, Cooper Ulrike, Dockhorn-Dworniczak Barbara, Rossenbach Christiana, Luna-Aguirre Claudia M, Barrera-Saldaña Hugo A, Machado José C, Costa José L, Yacobi Rinat, Tabibian-Keissar Hilla, Buglioni Simonetta, Ronchetti Livia, Douglas-Berger Lotte, Dubbink Hendrikus J, Alorini Mohammed, Sabourin Jean-Christophe, Rojo Federico
Abstract excerpt
Treatment of colorectal cancer (CRC) with monoclonal antibodies against epidermal growth factor receptor requires the assessment of the mutational status of exons 2, 3, and 4 of the NRAS and KRAS oncogenes. Moreover, the mutational status of exon 15 of the BRAF oncogene is a marker of poor prognosis in CRC. The Idylla NRAS-BRAF Mutation Test is a reliable, simple (<2 minutes hands-on time), and quick (<2 hours...
Topics
- Colorectal Neoplasms
- DNA Mutational Analysis
- GTP Phosphohydrolases
- Humans
- Membrane Proteins
- Mutation
- Proto-Oncogene Proteins B-raf
